- Bay Area Times
- Posts
- Neuralink raises $280M Series D from Founders Fund, after FDA authorized its 1st clinical trial
Neuralink raises $280M Series D from Founders Fund, after FDA authorized its 1st clinical trial
Bay Area Times
August 08, 2023
Brought to you by:
Hey, welcome to today's Bay Area Times daily newsletter. If you haven't yet already, follow us on Twitter.
Click here if you’re interested in advertising to our audience of 125K+ readers. We’re sold out weeks in advance, so please get in touch as soon as possible.
Top stories today:
1. Neuralink raises $280M Series D from Founders Fund
2. Softbank Vision Funds: #1 has $12B in gans, #2 $19B in losses
3. PayPal launches stablecoin PayPal USD
4. Zoom Clips launches in beta, taking aim at Loom
5. Palantir revenue +13% to $533M in Q2, net margin 5%
6. China's exports -14.5% YoY, imports -12.4% in July, worse than expected
0. Data and calendar
All values as of 6 AM ET / 3 AM PT, other than S&P500 close (4 PM ET / 1 PM PT).
All times are ET.
